Stockbridge Partners’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-893,430
Closed -$6.09M 16
2022
Q3
$6.09M Sell
893,430
-6,472,250
-88% -$108M 0.17% 16
2022
Q2
$144M Sell
7,365,680
-1,847,761
-20% -$38.7M 3.78% 12
2022
Q1
$200M Sell
9,213,441
-21,489
-0.2% -$456K 4.31% 11
2021
Q4
$217M Sell
9,234,930
-702,558
-7% -$16.8M 4.39% 10
2021
Q3
$260M Buy
9,937,488
+532,903
+6% +$12.9M 5.35% 6
2021
Q2
$228M Buy
9,404,585
+1,435,138
+18% +$35.3M 4.85% 9
2021
Q1
$199M Buy
7,969,447
+6,107,260
+328% +$162M 4.84% 8
2020
Q4
$51.1M Buy
+1,862,187
New +$50M 1.19% 11

Other funds holding SHC

Stockbridge Partners's SHC Position: Q4 2022 in Review

Stockbridge Partners sold out of Sotera Health (SHC) in Q4 2022, closing a stake of 893,430 shares — an estimated $6.09M sold.

Stockbridge Partners first reported a position in SHC in Q4 2020 and held it in 8 quarters. The position peaked at $260M in Q3 2021. 172 funds tracked by Wall St. Rank hold SHC as of Q4 2022.

  • Stockbridge Partners reported no remaining Sotera Health position as of Q4 2022 after selling out during the quarter.
  • Stockbridge Partners sold 893,430 Sotera Health shares in Q4 2022, an estimated $6.09M.
  • Stockbridge Partners first reported a position in Sotera Health in Q4 2020 and held it in 8 quarters.
  • Stockbridge Partners's Sotera Health position peaked at $260M in Q3 2021.
  • 172 funds tracked by Wall St. Rank held Sotera Health as of Q4 2022.

Based on Stockbridge Partners's 13F filing for Q4 2022, filed 14 Feb 2023.